BioSpace News Archive

Hormone Replacement Therapy Market Growth Outlook Trends, and Forecast 2021- 2031

Albany NY, United States: The global hormone replacement therapy market is anticipated to witness slow growth during the forecast period between 2021 and 2031.

May 25, 2022
·
6 min read
Cosmeceuticals Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2027

Albany NY, United States: The global cosmeceuticals market is anticipated to witness strong growth during the forecast period between 2021 and 2031.

May 25, 2022
·
5 min read
Biobanks Market Demand and Global Competitive Insights 2031

Albany NY, United States: The global biobanks market is expected to witness strong growth during the forecast period between 2021 and 2031.

May 25, 2022
·
5 min read
Mobile Cardiac Telemetry Systems Market Segmentation and Forecast Analysis up to 2031

Albany NY, United States: Mobile cardiac telemetry is a cardiac monitoring method that uses a small portable device to monitor a patient’s cardiac activity.

May 25, 2022
·
5 min read
Bio NC

Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries

Pfizer Inc. launched ‘An Accord for a Healthier World.’ This groundbreaking initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the U.S. or the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.

May 25, 2022
·
8 min read
Biotech Bay

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology

Guardant Health, Inc. announced that the first blood-based cancer testing services in Europe based on Guardant Health’s industry-leading digital sequencing platform are now available at the VHIO liquid biopsy testing facility in Barcelona.

May 25, 2022
·
6 min read
Ellipses Pharma and SunRock Biopharma Enter Into a Licensing Agreement for a First-in-class Bifunctional HER3:TRAIL Fusion Protein

SunRock Biopharma S.L. announce that they have entered into an exclusive licensing agreement for SRB22, a fully human bifunctional HER3:TRAIL fusion protein, which going forward will be known as EP0017.

May 25, 2022
·
3 min read
Lone Star Bio

Vizient to Present at FDA CDER Quality Management Maturity Workshop

Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop , which is being held May 24-25, 2022.

May 25, 2022
·
2 min read
ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the presentation of clinical data on linzagolix, an oral GnRH antagonist.

May 25, 2022
·
9 min read
Genetown

CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory FrameworkCE

CENTOGENE today announced that its cloud-based Software as a Service (SaaS) platform for the identification, prioritization, and classification of human genetic variants is now CE-marked under the In Vitro Diagnostics Directive (98/79/EC).

May 25, 2022
·
5 min read